To conclude, selective Pten inhibition in Plp1-expressing glial cells presents a valuable approach where increased colonic glial and neuronal numbers and slower intestinal transit times would be advantageous (e.g., short-bowel syndrome and rapid transit disorders) and warrants further studies. The gene discussed is PLP1; the disease is short bowel syndrome.